Recall Z-2779-2016

Biomerieux France Chemin De L'Or · initiated April 15, 2016

Class III Terminated

Class III – products unlikely to cause any adverse health reaction but that violate FDA labeling or manufacturing laws

Product

VIDAS NT-pro-BNP Product Usage: VIDAS NTproBNP (PBNP) is an automated quantitative test for use on the instruments of the VIDAS family for the determination of N terminal fragment of Btype natriuretic peptide in human serum or plasma (lithium heparin) using the ELFA technique (EnzymeLinked Fluorescent Assay). The VIDAS NTproBNP (PBNP) test is used as an aid in the diagnosis of suspected congestive heart failure.

Codes / lots: Reference number: 30449-01, Lot #1004474560.

Reason for recall

Due to a packaging error; The kit does not contain the correct number of C1 or C2 control vials.

FDA-determined cause: Packaging

Action taken

bioMerieux. sent an Urgent Product Removal Notice letter dated April 26, 2016 to customers via FedEx. The letter identified the affected product, problem and actions to be taken. Customers were instructed to check for affected products in their inventory and discard the incomplete products. Customers were asked to complete the attached Acknowledgement Form and return it via fax to bioMerieux. For questions contact your local bioMerieux Clinical Customer Service organization at (800) 682-2666.

Details

Recall number
Z-2779-2016
Initiated
April 15, 2016
Posted by FDA
September 10, 2016
Terminated
July 21, 2017
Product code
NBC – Test, Natriuretic Peptide
Quantity
229 kits
Distribution
US Nationwide Distribution in the states of: AL, AZ, CA, FL, GA, IA, KS, KY, MA, MI, MN, NC, NE, NJ, NY, OH, SC, TX, VA and WV.
Recalling firm
Biomerieux France Chemin De L'Or, Marcy L'Etoile

Official FDA recall record